Literature DB >> 3920355

Neurological findings in patients with the fragile-X syndrome.

P F Finelli, S M Pueschel, T Padre-Mendoza, M M O'Brien.   

Abstract

We report two brothers with previously unexplained mental retardation and seizures who had dysmorphic facial features, macro-orchidism, and a fragile site at the X chromosome. This recently described syndrome is the second most common chromosome aberration associated with mental retardation after Down's syndrome. In order to determine the prevalence of seizures and the frequency of specific neurological features, we studied a total of 17 patients with the fragile X syndrome. 41% had grand mal seizures; 41% had extensor plantar responses; 47% had hyperactive behaviour and 65% exhibited stereotypics; 59% had incoordination and 35% had blepharospasm. We emphasise the need for chromosome analysis of patients with unexplained mental retardation, specific phenotypic abnormalities, and large testes.

Entities:  

Mesh:

Year:  1985        PMID: 3920355      PMCID: PMC1028216          DOI: 10.1136/jnnp.48.2.150

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Familial sex-linked mental retardation.

Authors:  H RENPENNING; J W GERRARD; W A ZALESKI; T TABATA
Journal:  Can Med Assoc J       Date:  1962-11-03       Impact factor: 8.262

2.  X-linked mental retardation associated with macro-orchidism.

Authors:  G Turner; C Eastman; J Casey; A McLeay; P Procopis; B Turner
Journal:  J Med Genet       Date:  1975-12       Impact factor: 6.318

3.  X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28.

Authors:  G R Sutherland; P L Ashforth
Journal:  Hum Genet       Date:  1979-04-17       Impact factor: 4.132

4.  X-linked mental deficiency megalotestes syndrome.

Authors:  R H Ruvalcaba; S A Myhre; E C Roosen-Runge; J B Beckwith
Journal:  JAMA       Date:  1977-10-10       Impact factor: 56.272

5.  More on marker X chromosomes, mental retardation and macro-orchidism.

Authors:  P A Jacobs; M Mayer; E Rudak; J Gerrard; E J Ives; M H Shokeir; J Hall; M Jennings; H Hoehn
Journal:  N Engl J Med       Date:  1979-03-29       Impact factor: 91.245

6.  Marker X chromosomes, mental retardation and macro-orchidism.

Authors:  G Turner; R Till; A Daniel
Journal:  N Engl J Med       Date:  1978-12-28       Impact factor: 91.245

7.  X-linked mental retardation, macro-orchidism, and the Xq27 fragile site.

Authors:  G Turner; A Daniel; M Frost
Journal:  J Pediatr       Date:  1980-05       Impact factor: 4.406

8.  X-linked mental retardation with macro-orchidism and marker X chromosomes.

Authors:  P N Howard-Peebles; G R Stoddard
Journal:  Hum Genet       Date:  1979-09       Impact factor: 4.132

9.  Familial X-linked mental retardation with an X chromosome abnormality.

Authors:  J Harvey; C Judge; S Wiener
Journal:  J Med Genet       Date:  1977-02       Impact factor: 6.318

10.  Heterozygous expression of X-linked mental retardation and X-chromosome marker fra(X)(q27).

Authors:  G Turner; R Brookwell; A Daniel; M Selikowitz; M Zilibowitz
Journal:  N Engl J Med       Date:  1980-09-18       Impact factor: 91.245

View more
  6 in total

1.  Brief report: screening children with autism for fragile-X syndrome and phenylketonuria.

Authors:  S M Pueschel; R Herman; G Groden
Journal:  J Autism Dev Disord       Date:  1985-09

2.  Clinico-neurological investigations in the fra(X) form of mental retardation.

Authors:  P Vieregge; U Froster-Iskenius
Journal:  J Neurol       Date:  1989-02       Impact factor: 4.849

3.  Fragile X syndrome: genetic predisposition to psychopathology.

Authors:  J D Bregman; J F Leckman; S I Ort
Journal:  J Autism Dev Disord       Date:  1988-09

Review 4.  Fragile X syndrome: A review of clinical management.

Authors:  Reymundo Lozano; Atoosa Azarang; Tanaporn Wilaisakditipakorn; Randi J Hagerman
Journal:  Intractable Rare Dis Res       Date:  2016-08

5.  Hyperactivity and the fragile X syndrome.

Authors:  S Einfeld; W Hall; F Levy
Journal:  J Abnorm Child Psychol       Date:  1991-06

6.  Acamprosate in a mouse model of fragile X syndrome: modulation of spontaneous cortical activity, ERK1/2 activation, locomotor behavior, and anxiety.

Authors:  Tori L Schaefer; Matthew H Davenport; Lindsay M Grainger; Chandler K Robinson; Anthony T Earnheart; Melinda S Stegman; Anna L Lang; Amy A Ashworth; Gemma Molinaro; Kimberly M Huber; Craig A Erickson
Journal:  J Neurodev Disord       Date:  2017-06-12       Impact factor: 4.025

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.